Onesource Specialty Pharma is trading 0.53% upper at Rs 1,830.00 as compared to its last closing price. Onesource Specialty Pharma has been trading in the price range of 1,860.00 & 1,779.30. Onesource Specialty Pharma has given 0.51% in this year & 0.22% in the last 5 days. There are 4 analysts who have initiated coverage on Onesource Specialty Pharma. There are 3 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 4.60 Crores in its last quarter.Listed peers of Onesource Specialty Pharma include Sun Pharmaceutical Industries (0.90%), Cipla (-0.49%), Divi's Laboratories (-2.41%).The Mutual Fund holding in Onesource Specialty Pharma was at 10.13% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Onesource Specialty Pharma was at 17.50% in 31 Mar 2026. The FII holding has decreased from the last quarter.
Updated on May 16, 2026, 04:59 AM UTC
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,879.90 | 0.90 | 4,51,076.67 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Moderately Bullish | 1,431.55 | -0.49 | 1,16,013.10 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Bullish | 6,755.00 | -2.41 | 1,78,679.99 | 78.61 | 11.52 | 0.46 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,386.00 | -0.52 | 1,48,148.92 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bullish | 1,336.95 | 2.62 | 1,11,584.24 | 18.63 | 3.14 | 0.63 | 2.34 |
| Meeting Date | Purpose |
|---|---|
| 2026-05-13 | Audited Results |
| 2026-01-23 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-05 | Audited Results |
Onesource Specialty Pharma is trading at 1830.00 as on Fri May 15 2026 09:59:03. This is 0.53% upper as compared to its previous closing price of 1820.30.
The market capitalization of Onesource Specialty Pharma is 20979.60 Cr as on Fri May 15 2026 09:59:03.
The average broker rating on Onesource Specialty Pharma is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Onesource Specialty Pharma is 2249.65 whereas the 52 wk low is 1075.00
Onesource Specialty Pharma can be analyzed on the following key metrics -
Onesource Specialty Pharma reported a net profit of -73.80 Cr in 2026.
The Mutual Fund Shareholding was 10.13% at the end of 31 Mar 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.